Myeloid Malignancies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-11-22
Clinical Trial Update: MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies [NA]
The clinical trial MyeloGen investigating germline testing for predisposition to myeloid malignancies has been withdrawn. No further details…